Skip to main content
    6

    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.49
    -0.02 (-4.60%)

    Market Cap: $1.82M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) to earn -$3.45 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.00M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$3.58.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates rise 70.0%.

    Fiscal year ending Dec 31, 2026
    -$3.45
    EPS consensus, revenue $1.00M
    Fiscal year ending Dec 31, 2027
    -$3.58
    EPS consensus, revenue $1.70M

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$3.45-$3.45 to -$3.451$1.00M$1.00M to $1.00M2
    Dec 31, 2027-$3.58-$3.58 to -$3.581$1.70M$1.40M to $2.00M2

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.80-$0.87 to -$0.704$311100$294000 to $3255004

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 0 upward and 1 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202601
    Fiscal year ending Dec 31, 202700

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$7.88.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$3.45-$3.18-$3.18-$7.88-$7.88N/A

    Frequently Asked Questions About SXTP

    What is the SXTP stock forecast?

    Consensus analyst estimates put 60 Degrees Pharmaceuticals, Inc. Common Stock's EPS at -$3.45 for the fiscal year ending Dec 31, 2026, on revenue of $1.00M.

    What EPS do analysts expect from SXTP next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$3.45, with estimates from -$3.45 to -$3.45 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$3.58, with estimates from -$3.58 to -$3.58 from 1 analyst.

    What revenue do analysts expect from 60 Degrees Pharmaceuticals, Inc. Common Stock next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.00M, with estimates from $1.00M to $1.00M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.70M, with estimates from $1.40M to $2.00M.

    How many analysts cover SXTP?

    1 analyst estimates EPS for 60 Degrees Pharmaceuticals, Inc. Common Stock for the fiscal year ending Dec 31, 2026.